期刊文献+

3D腹腔镜下根治性顺行模块化胰脾切除术治疗胰腺体尾部恶性肿瘤的临床疗效 被引量:2

Clinical efficacy of 3D laparoscopic radical antegrade modular pancreatosplenectomy for carcinoma of pancreatic body and tail
下载PDF
导出
摘要 目的探讨3D腹腔镜下根治性顺行模块化胰脾切除术治疗胰腺体尾部恶性肿瘤的临床应用价值。方法回顾性分析应用3D腹腔镜行根治性顺行模块化胰脾切除术的12例患者的临床资料。其中男性9例,女性3例;年龄42~71岁,中位年龄56岁。所有患者均为胰腺体尾部恶性肿瘤患者。结果所有患者均顺利完成手术。手术时间151 min(128~205 min),术中出血量260 m L(200~380 m L),术后住院时间11 d(8~16 d)。4例术后发生胰瘘,均为生化漏,均经抑酶和引流等保守治愈。无围手术期死亡病例。术后随访时间3~6个月,患者生活质量好,无肿瘤复发。结论应用3D腹腔镜行根治性顺行模块化胰脾切除术治疗胰体尾部的恶行肿瘤具有安全有效的特点,值得在临床推广和应用。 Objective To explore the clinical value of 3D laparoscopic radical antegrade modular pancreatosplenectomy for carcinoma of pancreatic body and tail.Methods The clinical data of 12 patients who underwent 3D laparoscopic radical antegrade modular pancreatosplenectomy were retrospective analyzed.There were 9 males and 3 females;aged 42-71 years,with a median age of 56 years.All patients were malignant tumors of the body and tail of the pancreas.Results All patients successfully completed the operation.The operation time was 151 min(128-205 min),the intraoperative blood loss was 260 mL(200-380 mL),and the postoperative hospital stay was 11 days(8-16 days).Four patients had pancreatic fistula after operation,all of which were biochemical sputum,which were conservatively cured by inhibition of enzymes and drainage.There were no perioperative deaths.After 3 to 6 months of follow-up,the patient's quality of life was good and there was no tumor recurrence.Conclusions The use of 3D laparoscopic radical antegrade modular pancreatosplenectomy for the treatment of malignant tumors in the body and tail of the pancreas is safe and effective,and it is worthy of clinical promotion and application.
作者 陈庆民 贾宝兴 王英超 刘松阳 纪柏 刘亚辉 Chen Qingmin;Jia Baoxing;Wang Yingchao;Liu Songyang;Ji Bai;Liu Yahui(Hepatobiliary Surgery,the First Hospital of Jilin University,Changchun 130021,China)
出处 《实用肿瘤杂志》 CAS 2019年第4期294-297,共4页 Journal of Practical Oncology
关键词 胰腺肿瘤/外科学 腹腔镜检查/方法 胰腺切除术/方法 脾切除术 治疗结果 回顾性研究 pancreatic neoplasms/surgery laparoscopy/methods pancreatectomy/methods splenectomy treatment outcome retrospective studies
  • 相关文献

参考文献4

二级参考文献39

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin, 2009,59:225-249.
  • 2Hidalgo M. Pancreatic cancer. N Engi J Med, 2010, 362: 1605-1617.
  • 3Bilimoria KY, Bentrem DJ, Ko CY, et al. National failure to operate on early stage pancreatic cancer. Ann Surg, 2007, 246 : 173-180.
  • 4Larghi A, Verna EC, Lecca PG, et al. Screening for pancreat ic cancer in high-risk individuals: a call for endoscopic ultra- sound. Clin Cancer Res, 2009,15 : 1907-1914.
  • 5Gemmel C, Eickhoff A, Helmstadter L, et al. Pancreatic cancer screening: state of the art. Expert Rev Gastroenterol Hepatol, 2009,3 : 89-96.
  • 6Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Border- line reseetable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol, 2006,13: 1035-1046.
  • 7Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg, 2008,206:833-846 ; discussion 846-838.
  • 8Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg, 2007,246 :52 -60.
  • 9Evans DB, Farnell MB, Lillemoe KD, et al. Surgical treatment of resectable and borderline resectable pancreas cancer: expert con sensus statement. Ann Surg Oncol, 2009,16 : 1736-1744.
  • 10Jamieson NB, Foulis AK, Oien KA, et al. Positive mobiliza tion margins alone do not influence survival following pancre atico-duodenectomy for pancreatic ductal adenoearcinoma. Ann Surg, 2010,251 : 1003-1010.

共引文献54

同被引文献22

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部